HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 99 filers reported holding HARVARD BIOSCIENCE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $103,200 | -47.5% | 24,000 | -32.9% | 0.00% | – |
| Q2 2023 | $196,427 | +152.6% | 35,779 | +93.3% | 0.00% | – |
| Q1 2023 | $77,759 | +15.8% | 18,514 | -23.7% | 0.00% | – |
| Q4 2022 | $67,170 | -19.1% | 24,249 | +5.5% | 0.00% | – |
| Q2 2022 | $83,000 | -74.5% | 22,989 | -50.2% | 0.00% | – |
| Q4 2021 | $326,000 | +91.8% | 46,122 | +88.9% | 0.00% | – |
| Q3 2021 | $170,000 | -12.8% | 24,416 | +4.1% | 0.00% | – |
| Q2 2021 | $195,000 | +126.7% | 23,455 | +48.2% | 0.00% | – |
| Q1 2021 | $86,000 | -58.0% | 15,828 | -76.0% | 0.00% | – |
| Q2 2020 | $205,000 | +318.4% | 66,000 | +200.7% | 0.00% | – |
| Q1 2020 | $49,000 | -51.0% | 21,949 | -55.6% | 0.00% | – |
| Q2 2019 | $100,000 | -73.9% | 49,459 | -35.4% | 0.00% | – |
| Q1 2018 | $383,000 | +560.3% | 76,610 | +664.8% | 0.00% | – |
| Q1 2015 | $58,000 | -9.4% | 10,017 | -29.1% | 0.00% | – |
| Q2 2014 | $64,000 | -64.8% | 14,128 | -63.5% | 0.00% | – |
| Q4 2013 | $182,000 | -72.0% | 38,758 | -68.6% | 0.00% | – |
| Q3 2013 | $649,000 | +637.5% | 123,345 | +563.1% | 0.00% | – |
| Q2 2013 | $88,000 | – | 18,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harvey Partners, LLC | 1,020,036 | $7,120,000 | 5.32% |
| Portolan Capital Management | 2,358,010 | $16,459,000 | 1.20% |
| Acuitas Investments, LLC | 375,836 | $2,623,000 | 1.14% |
| Parkman Healthcare Partners LLC | 475,367 | $3,318,000 | 0.84% |
| Adirondack Research & Management Inc. | 90,020 | $628,000 | 0.76% |
| Archon Capital Management LLC | 736,236 | $5,139,000 | 0.73% |
| BARD ASSOCIATES INC | 294,697 | $2,057,000 | 0.70% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,621,775 | $11,320,000 | 0.65% |
| GLOBEFLEX CAPITAL L P | 268,466 | $1,874,000 | 0.41% |
| Monarch Partners Asset Management LLC | 330,083 | $2,304,000 | 0.34% |